Key result
Deep breathing and transcutaneous auricular vagus nerve stimulation both increased heart rate variability parameters in RA and SLE patients (17-31% and 18-25% increases, respectively).
Why the study?
Rheumatoid arthritis and systemic lupus erythematosus are associated with impaired autonomic nervous system and vagus nerve function, but no direct comparison of electrical versus physiological vagus nerve stimulation has been made.
Does deep breathing or transcutaneous auricular vagus nerve stimulation improve heart rate variability in healthy participants and patients with rheumatoid arthritis or systemic lupus erythematosus?
Does deep breathing or transcutaneous auricular vagus nerve stimulation improve heart rate variability in healthy participants and patients with rheumatoid arthritis or systemic lupus erythematosus?
Both deep breathing and transcutaneous auricular vagus nerve stimulation effectively increase heart rate variability in patients with rheumatoid arthritis or systemic lupus erythematosus, suggesting potential as a non-pharmacological autonomic modulation therapy.
Rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) are associated with an impaired autonomic nervous system and vagus nerve function. Electrical or physiological (deep breathing-DB) vagus nerve stimulation (VNS) could be a potential treatment approach, but no direct comparison has been made. In this study, the effect of transcutaneous auricular VNS (taVNS) and DB on vagal tone was compared in healthy participants and RA or SLE patients. The vagal tone was estimated using time-domain heart-rate variability (HRV) parameters. Forty-two healthy participants and 52 patients performed 30 min of DB and 30 min of taVNS on separate days. HRV was recorded before and immediately after each intervention. For the healthy participants, all HRV parameters increased after DB (SDNN + RMSSD: 21-46%), while one HRV parameter increased after taVNS (SDNN: 16%). For the patients, all HRV parameters increased after both DB (17-31%) and taVNS (18-25%), with no differences between the two types of VNS. DB was associated with the largest elevation of the HRV parameters in healthy participants, while both types of VNS led to elevated HRV parameters in the patients. The findings support a potential use of VNS as a new treatment approach, but the clinical effects need to be investigated in future studies.
No takes yet. Share an insight, caveat, or question.
Jensen et al. (2022) studied Rheumatoid arthritis (RA) or systemic lupus erythematosus (SLE) (n=94). Deep breathing (DB) and transcutaneous auricular vagus nerve stimulation (taVNS) vs. Baseline and each other was evaluated on Vagal tone estimated using time-domain heart-rate variability (HRV) parameters. Deep breathing and transcutaneous auricular vagus nerve stimulation both increased heart rate variability parameters in RA and SLE patients (17-31% and 18-25% increases, respectively).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: